History
  • No items yet
midpage
Hologic, Inc. v. SenoRx, Inc.
639 F.3d 1329
| Fed. Cir. | 2011
Read the full case

Background

  • Hologic sued SenoRx alleging infringement of the '142 patent related to balloon brachytherapy devices.
  • The district court construed claim 1 to require asymmetry about the longitudinal axis; found claim 1 anticipated by Ashpole and denied summary judgment as to claim 8.
  • The district court held claim 1 invalid for anticipation; the jury later found claim 8 anticipated and obvious.
  • Hologic appealed, challenging the claim construction and the validity determinations.
  • The Federal Circuit reversed the invalidity ruling, remanding for proceedings consistent with their construction and holding that the district court erred in its interpretation of asymmetry.
  • Costs were awarded to Hologic.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Proper construction of 'asymmetrically located and arranged within the expandable surface' Hologic contends asymmetry is about the longitudinal axis. SenoRx argues no axis limitation; constructions should rely on the specification. Claim 1 construed to asymmetry about the longitudinal axis; not limited to other interpretations.
Relation between claim 1 and claim 6 (claim differentiation) Different terms justify different scope; claim 1 may be broader. Claim 6 explicitly ties symmetry to a longitudinal axis; differentiation supports distinct readings. No basis to rewrite claim 1 beyond its plain language; differences with claim 6 do not alter claim 1’s asymmetry understanding.
Anticipation/inoperability under prior art (Ashpole/Williams) Ashpole discloses predetermined asymmetric isodose curves. Ashpole does not disclose axis-relative asymmetry; Williams is not clearly anticipatory. Ashpole does not render claim 1 invalid under the construed meaning; Williams not controlling.
Enablement/operability of the phrase 'disposed completely within the expandable outer surface and spaced apart from the apparatus volume' The phrasing is feasible under the specification; no fatal lack of enablement. The language is awkward and could render the claim inoperable. Court agrees with district court that the wording is consistent with the specification and does not render the claim invalid.

Key Cases Cited

  • Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (claims are read in light of the specification and prosecution history)
  • Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576 (Fed. Cir. 1996) (intrinsic evidence governs claim construction)
  • Iovate Health Scis., Inc. v. Bio-Engineered Supplements & Nutrition, Inc., 586 F.3d 1376 (Fed. Cir. 2009) (summary judgment de novo; standard for claim construction and validity)
  • Cybor Corp. v. FAS Techs., 138 F.3d 1448 (Fed. Cir. 1998) (law reviewing claim construction de novo (en banc))
Read the full case

Case Details

Case Name: Hologic, Inc. v. SenoRx, Inc.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Feb 24, 2011
Citation: 639 F.3d 1329
Docket Number: 2010-1235
Court Abbreviation: Fed. Cir.